OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies
Jingqin Zhong, Wangjun Yan, Chunmeng Wang, et al.
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 11, pp. 1503-1521
Open Access | Times Cited: 44
Jingqin Zhong, Wangjun Yan, Chunmeng Wang, et al.
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 11, pp. 1503-1521
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Anticancer effect of terpenes: focus on malignant melanoma
Paula Wróblewska-Łuczka, Justyna Cabaj, Julia Bargieł, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 5, pp. 1115-1125
Open Access | Times Cited: 44
Paula Wróblewska-Łuczka, Justyna Cabaj, Julia Bargieł, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 5, pp. 1115-1125
Open Access | Times Cited: 44
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 40
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 40
VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives
Mohammad Malekan, Nikolas K. Haass, Ghasem Rahmatpour Rokni, et al.
Life Sciences (2024) Vol. 345, pp. 122563-122563
Closed Access | Times Cited: 17
Mohammad Malekan, Nikolas K. Haass, Ghasem Rahmatpour Rokni, et al.
Life Sciences (2024) Vol. 345, pp. 122563-122563
Closed Access | Times Cited: 17
Melanoma Derived Exosomes Amplify Radiotherapy Induced Abscopal Effect via IRF7/I‐IFN Axis in Macrophages
Lu Wang, Kangjie Shen, Zixu Gao, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 12
Lu Wang, Kangjie Shen, Zixu Gao, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 12
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
Anna De Lucia, L. Mazzotti, Anna Gaimari, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Anna De Lucia, L. Mazzotti, Anna Gaimari, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Ferroptosis as a promising therapeutic strategy for melanoma
Na Ta, Xiaodong Jiang, Yongchun Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19
Na Ta, Xiaodong Jiang, Yongchun Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19
Phytochemicals as Immunomodulatory Agents in Melanoma
Claudio Tabolacci, Daniela De Vita, Antonio Facchiano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2657-2657
Open Access | Times Cited: 14
Claudio Tabolacci, Daniela De Vita, Antonio Facchiano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2657-2657
Open Access | Times Cited: 14
Role and Function of Receptor Tyrosine Kinases in BRAF Mutant Cancers
Bernhard Biersack, Lubna H. Tahtamouni, Michael Höpfner
Receptors (2024) Vol. 3, Iss. 1, pp. 58-106
Open Access | Times Cited: 4
Bernhard Biersack, Lubna H. Tahtamouni, Michael Höpfner
Receptors (2024) Vol. 3, Iss. 1, pp. 58-106
Open Access | Times Cited: 4
Unraveling lipid metabolism reprogramming for overcoming drug resistance in melanoma
Ruilong Wang, Yan Qin, Xiao Liu, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116122-116122
Closed Access | Times Cited: 4
Ruilong Wang, Yan Qin, Xiao Liu, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116122-116122
Closed Access | Times Cited: 4
Current and emerging treatment options for BRAFV600-mutant melanoma
Anadil Javaid, Tobias Peres, Javier Pozas, et al.
Expert Review of Anticancer Therapy (2025)
Closed Access
Anadil Javaid, Tobias Peres, Javier Pozas, et al.
Expert Review of Anticancer Therapy (2025)
Closed Access
Global trends and emerging insights in BRAF and MEK inhibitor resistance in melanoma: a bibliometric analysis
Jianhao Bai, Zhongqi Wan, Wanru Zhou, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Jianhao Bai, Zhongqi Wan, Wanru Zhou, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Histone deacetylases in the regulation of cell death and survival mechanisms in resistant BRAF-mutant cancers
Bernhard Biersack, Bianca Nitzsche, Michael Höpfner
Cancer Drug Resistance (2025)
Open Access
Bernhard Biersack, Bianca Nitzsche, Michael Höpfner
Cancer Drug Resistance (2025)
Open Access
Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cells
Jerry H. Houl, Rozita Bagheri‐Yarmand, Muthusamy Kunnimalaiyaan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Jerry H. Houl, Rozita Bagheri‐Yarmand, Muthusamy Kunnimalaiyaan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Immunomodulation on tumor immune microenvironment in acquired targeted therapy resistance and implication for immunotherapy resistance
Ming-Yu Chou, Muh‐Hwa Yang
Translational Oncology (2025) Vol. 54, pp. 102353-102353
Closed Access
Ming-Yu Chou, Muh‐Hwa Yang
Translational Oncology (2025) Vol. 54, pp. 102353-102353
Closed Access
Shielding the Skin
Aakriti Saini, Diksha Gulati, Shivanki Joshi
IGI Global eBooks (2025), pp. 345-360
Closed Access
Aakriti Saini, Diksha Gulati, Shivanki Joshi
IGI Global eBooks (2025), pp. 345-360
Closed Access
Pathway activation model for personalized prediction of drug synergy
Quang Thinh Trac, Yue Huang, Tom Erkers, et al.
(2025)
Open Access
Quang Thinh Trac, Yue Huang, Tom Erkers, et al.
(2025)
Open Access
Exploring Potential Therapeutic Applications of Tazarotene: Gene Regulation Mechanisms and Effects on Melanoma Cell Growth
Chun‐Hua Wang, Lu‐Kai Wang, Fu‐Ming Tsai
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 237-237
Open Access
Chun‐Hua Wang, Lu‐Kai Wang, Fu‐Ming Tsai
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 237-237
Open Access
QCM biosensor based on silver aggregates and DNA ligase for ultrasensitive detection of BRAF-V600E single mutant gene in melanoma
Jia Guo, Ruming Liu, Yuan Ge, et al.
Talanta (2025) Vol. 292, pp. 127997-127997
Closed Access
Jia Guo, Ruming Liu, Yuan Ge, et al.
Talanta (2025) Vol. 292, pp. 127997-127997
Closed Access
BRAF Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With BRAF V600E -Mutated Lung Adenocarcinoma
Pierre de Priester, Lodovica Zullo, Damien Vasseur, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
Pierre de Priester, Lodovica Zullo, Damien Vasseur, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
In Vitro and In Silico Evaluation of the Anticancer and Antiparasitic Activities of New 2‐Methoxy Azachalconium Bromides
Mai F. AlSakhen, Sana I. Kanaan, Khaled Saleh, et al.
ChemistrySelect (2025) Vol. 10, Iss. 16
Closed Access
Mai F. AlSakhen, Sana I. Kanaan, Khaled Saleh, et al.
ChemistrySelect (2025) Vol. 10, Iss. 16
Closed Access
Characteristics of the MicroRNA‐Processing Enzymes in Melanocytic Skin Lesions: Dicer and DGCR8 Are Potential Biomarkers for Primary Cutaneous Melanomas
Fabiola Schafer, Enrique Bellolio, Tatiana Sepúlveda, et al.
Experimental Dermatology (2025) Vol. 34, Iss. 5
Closed Access
Fabiola Schafer, Enrique Bellolio, Tatiana Sepúlveda, et al.
Experimental Dermatology (2025) Vol. 34, Iss. 5
Closed Access
Naturally-derived phenethyl isothiocyanate modulates apoptotic induction through regulation of the intrinsic cascade and resulting apoptosome formation in human malignant melanoma cells
Venetia Tragkola, Ioannis Anestopoulos, Sotiris Kyriakou, et al.
Toxicology Mechanisms and Methods (2024) Vol. 34, Iss. 9, pp. 985-999
Open Access | Times Cited: 3
Venetia Tragkola, Ioannis Anestopoulos, Sotiris Kyriakou, et al.
Toxicology Mechanisms and Methods (2024) Vol. 34, Iss. 9, pp. 985-999
Open Access | Times Cited: 3
Autophagy in BRAF-mutant cutaneous melanoma: recent advances and therapeutic perspective
Elisabetta Fratta, Giorgio Giurato, R. Guerrieri, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Elisabetta Fratta, Giorgio Giurato, R. Guerrieri, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Extracellular Vesicles in Cancer Drug Resistance: Implications on Melanoma Therapy
Alice Musi, Laura Bongiovanni
Cancers (2023) Vol. 15, Iss. 4, pp. 1074-1074
Open Access | Times Cited: 7
Alice Musi, Laura Bongiovanni
Cancers (2023) Vol. 15, Iss. 4, pp. 1074-1074
Open Access | Times Cited: 7
Development and in-depth characterization of BRAFi-resistant melanoma cell lines in vitro and in vivo
Aishwarya Saraswat, Ketan Patel
Experimental Cell Research (2024) Vol. 438, Iss. 1, pp. 114033-114033
Closed Access | Times Cited: 2
Aishwarya Saraswat, Ketan Patel
Experimental Cell Research (2024) Vol. 438, Iss. 1, pp. 114033-114033
Closed Access | Times Cited: 2
